Is this recall still active?

The FDA lists the recall as terminated (closed 11/25/2020). FDA has determined the recall is complete and closed it.

Checked Oct 26, 2026

Class IIDrug recallTerminated

Megestrol Acetate Oral Suspension recall

Recalled by Mckesson Corporation of Memphis, TN · FDA report 09/12/2018

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class: Class II; Moderate
Status: Terminated; Closed 11/25/2020
Recall started: 08/14/2018
Distribution: Nationwide

Reason for recall

Supterpotent Drug

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product: Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Lot and code info: Lot #: 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18
Quantity: 1531 cartons
Recall number: D-1172-2018
Event ID: 80830
Initiated by: Voluntary: Firm initiated

Where it was distributed

Nationwide within the United States

Nationwide

Recall timeline

08/14/2018Firm started the recall
09/05/2018FDA classified it as Class II
09/12/2018Published in the FDA enforcement report
11/25/2020FDA closed (terminated) the recall

Frequently asked questions

Why was Megestrol Acetate Oral Suspension recalled?: Supterpotent Drug
What does Class II mean?: Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?: Nationwide within the United States
Is this recall still active?: The FDA lists the recall as terminated (closed 11/25/2020). FDA has determined the recall is complete and closed it.

SEC company page: McKesson Corp (MCK) · financials and records from other agencies

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 09/12/2018 · Do not rely on openFDA to make decisions regarding medical care

Recall at a glance

Class: Class II
Status: Terminated
Type: Drug
Reported: 09/12/2018

FDA enforcement report search

What recall classes mean

Class IMost serious: A reasonable chance that using or being exposed to the product will cause serious health problems or death.
Class IIModerate: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Class IIILow risk: Use of or exposure to the product is not likely to cause adverse health consequences.

Classes are assigned by the FDA based on the health hazard.

If you have a recalled product

Stop using or eating it. Check the lot number, UPC or date code against the recall.
Return it to the store or follow the firm's instructions for a refund, repair or disposal.
For medicines, talk to your pharmacist or doctor before stopping a prescription.
Report problems to the FDA through MedWatch or to the CPSC at SaferProducts.gov.

Browse recalls

About this data

Recalls: Recall information comes from NHTSA, FDA, USDA, CPSC and other agencies. A product, vehicle or lot may be affected even if it is not listed here, and listings may be delayed. Check the official recall notice and contact the manufacturer or dealer to confirm whether your item is included.

DatenUS is a private website and is not affiliated with or endorsed by any government agency. We republish public data from the sources listed on this page. Data can be incomplete, delayed or wrong. Always check the original source before you make a decision.

Our servers read this data automatically from government sources. Errors can come from the source itself or from the way we read, process or display it, and we do not guarantee that it is accurate, complete or current. Verify anything important with the official source.

Report an error Read the full disclaimer